Dr. Laleh Merikhi, M.D

NPI: 1982865853
Total Payments
$13,511
2024 Payments
$3,091
Companies
44
Transactions
837
Medicare Patients
2,443
Medicare Billing
$255,819

Payment Breakdown by Category

Food & Beverage$13,110 (97.0%)
Education$380.91 (2.8%)
Other$20.00 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $13,110 831 97.0%
Education $380.91 5 2.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $20.00 1 0.1%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $2,201 118 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $2,010 143 $0 (2024)
Janssen Biotech, Inc. $1,781 104 $0 (2024)
Celgene Corporation $1,017 91 $0 (2024)
PFIZER INC. $752.14 52 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $692.26 46 $0 (2024)
Gilead Sciences, Inc. $617.10 38 $0 (2024)
QOL Medical, LLC $473.92 32 $0 (2024)
GENZYME CORPORATION $435.85 22 $0 (2024)
Merck Sharp & Dohme LLC $406.99 23 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,091 178 Janssen Biotech, Inc. ($563.62)
2023 $2,751 157 ABBVIE INC. ($448.05)
2022 $2,371 131 ABBVIE INC. ($578.46)
2021 $1,354 95 Janssen Biotech, Inc. ($341.29)
2020 $670.05 49 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($181.83)
2019 $1,674 118 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($568.44)
2018 $767.45 55 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($277.79)
2017 $832.66 54 Valeant Pharmaceuticals North America LLC ($221.00)

All Payment Transactions

837 individual payment records from CMS Open Payments — Page 1 of 34

Date Company Product Nature Form Amount Type
12/31/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $18.85 General
Category: Gastroenterology
12/23/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $18.42 General
Category: LIVER DISEASE
12/20/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $22.17 General
Category: Immunology
12/18/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $15.92 General
Category: Gastroenterology
12/17/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $18.30 General
Category: IMMUNOLOGY
12/16/2024 ABBVIE INC. CREON (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $20.00 General
Category: ENDOCRINOLOGY
12/08/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $17.27 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
12/04/2024 Janssen Biotech, Inc. TREMFYA (Drug), SIMPONI, SIMPONI ARIA Food and Beverage In-kind items and services $18.26 General
Category: Immunology
12/03/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Food and Beverage In-kind items and services $125.00 General
Category: Immunology
12/03/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $18.85 General
Category: GASTROENTEROLOGY
12/02/2024 Janssen Biotech, Inc. TREMFYA (Drug), SIMPONI, SIMPONI ARIA Food and Beverage In-kind items and services $16.70 General
Category: Immunology
12/02/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $14.43 General
11/25/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $21.46 General
Category: THERAPY FOR CSID
11/21/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $8.98 General
Category: Immunology
11/20/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $16.98 General
Category: Gastroenterology
11/19/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $22.82 General
Category: Immunology
11/19/2024 Janssen Biotech, Inc. TREMFYA (Drug), SIMPONI, SIMPONI ARIA Food and Beverage In-kind items and services $18.50 General
Category: Immunology
11/19/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $18.24 General
Category: Immunology
11/19/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $17.08 General
11/15/2024 Janssen Biotech, Inc. TREMFYA (Drug), SIMPONI, SIMPONI ARIA Food and Beverage In-kind items and services $13.23 General
Category: Immunology
11/13/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $125.00 General
Category: IMMUNOLOGY
11/13/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $18.50 General
Category: THERAPY FOR CSID
11/13/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $17.59 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
11/07/2024 Janssen Biotech, Inc. TREMFYA (Drug), SIMPONI, SIMPONI ARIA Food and Beverage In-kind items and services $19.47 General
Category: Immunology
11/05/2024 Janssen Biotech, Inc. TREMFYA (Drug), SIMPONI, SIMPONI ARIA Food and Beverage In-kind items and services $20.35 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 17 681 737 $615,510 $80,888
2022 14 557 605 $490,912 $56,966
2021 15 603 699 $483,627 $63,442
2020 12 602 666 $440,212 $54,524
Total Patients
2,443
Total Services
2,707
Medicare Billing
$255,819
Procedure Codes
58

All Medicare Procedures & Services

58 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 99 115 $40,135 $12,034 30.0%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 45 45 $85,388 $10,001 11.7%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 102 108 $172,260 $8,440 4.9%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 75 76 $137,940 $7,383 5.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 64 87 $20,445 $6,083 29.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 39 39 $17,160 $5,483 32.0%
91120 Test for tone and sensation of rectum and anus Office 2023 11 11 $17,732 $5,124 28.9%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 23 23 $38,962 $4,362 11.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 26 27 $12,690 $4,190 33.0%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 50 58 $13,340 $3,913 29.3%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 30 30 $13,140 $3,218 24.5%
91122 Study of rectum sensitivity and function Office 2023 11 11 $8,712 $2,714 31.2%
76981 Ultrasound scan of organ tissue for measuring elasticity Office 2023 25 25 $9,086 $2,194 24.1%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 26 26 $9,152 $1,783 19.5%
91065 Measurement of hydrogen in breath to test for stomach and bowel symptoms Office 2023 23 23 $6,578 $1,759 26.7%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 19 20 $4,282 $1,493 34.9%
91010 Study of esophagus to assess movement Facility 2023 13 13 $8,509 $711.54 8.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 92 111 $38,739 $10,669 27.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 86 97 $22,795 $7,232 31.7%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 91 93 $148,335 $6,792 4.6%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 31 31 $58,823 $6,790 11.5%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 54 54 $98,010 $5,807 5.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 41 41 $18,040 $4,676 25.9%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 38 51 $11,730 $3,027 25.8%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 28 28 $9,856 $2,545 25.8%

About Dr. Laleh Merikhi, M.D

Dr. Laleh Merikhi, M.D is a Gastroenterology healthcare provider based in Oakhurst, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2008. The National Provider Identifier (NPI) number assigned to this provider is 1982865853.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laleh Merikhi, M.D has received a total of $13,511 in payments from pharmaceutical and medical device companies, with $3,091 received in 2024. These payments were reported across 837 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($13,110).

As a Medicare-enrolled provider, Merikhi has provided services to 2,443 Medicare beneficiaries, totaling 2,707 services with total Medicare billing of $255,819. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Other Specialties Gastroenterology
  • Location Oakhurst, NJ
  • Active Since 06/23/2008
  • Last Updated 03/14/2025
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1982865853

Products in Payments

  • XIFAXAN (Drug) $1,375
  • STELARA (Biological) $1,118
  • ZEPOSIA (Drug) $1,064
  • RINVOQ (Biological) $700.56
  • XELJANZ (Drug) $684.71
  • DUPIXENT (Biological) $550.46
  • TREMFYA (Drug) $462.93
  • TRULANCE (Drug) $438.85
  • DIFICID (Drug) $371.82
  • ENTYVIO (Biological) $370.92
  • INTERSTIM (Device) $361.53
  • SKYRIZI (Biological) $350.64
  • LINZESS (Drug) $323.74
  • SUCRAID (Drug) $254.21
  • XIFAXANIBSD (Drug) $248.16
  • INJECTAFER (Drug) $234.50
  • HUMIRA (Biological) $220.36
  • Sucraid (Drug) $219.71
  • REMICADE (Biological) $215.20
  • GATTEX (Drug) $175.97

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Oakhurst